COVID-19 and hypertension: risks and management. A scientific statement on behalf of the British and Irish Hypertension Society
| dc.contributor.author | Clark, CE | |
| dc.contributor.author | McDonagh, STJ | |
| dc.contributor.author | McManus, RJ | |
| dc.contributor.author | Martin, U | |
| dc.date.accessioned | 2021-03-04T11:56:06Z | |
| dc.date.issued | 2021-01-22 | |
| dc.description.abstract | Hypertension is the single largest global contributor to disability-adjusted life years lost [1]. The majority of the population aged over 60 years have hypertension [2], and it has been suggested that they may be at increased risk from the effects of COVID-19. Despite this, and perhaps due to its ubiquity in the older population, current UK Government guidance does not identify people with hypertension as ʻat risk’ [3], however, other bodies such as the British Heart Foundation and the Health Service Executive in Ireland do [4, 5]. This article seeks to summarise and interpret the current evidence for and against an increase in COVID-19 risk and severity for those with raised blood pressure, and discusses the implications for the choice of anti-hypertensive treatment. | en_GB |
| dc.identifier.citation | Published online 22 January 2021 | en_GB |
| dc.identifier.doi | 10.1038/s41371-020-00451-x | |
| dc.identifier.uri | http://hdl.handle.net/10871/125002 | |
| dc.language.iso | en | en_GB |
| dc.publisher | Springer Nature | en_GB |
| dc.rights | © The Author(s) 2021. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. | en_GB |
| dc.title | COVID-19 and hypertension: risks and management. A scientific statement on behalf of the British and Irish Hypertension Society | en_GB |
| dc.type | Article | en_GB |
| dc.date.available | 2021-03-04T11:56:06Z | |
| dc.identifier.issn | 0950-9240 | |
| dc.description | This is the final version. Available on open access from Springer Nature via the DOI in this record | en_GB |
| dc.identifier.journal | Journal of Human Hypertension | en_GB |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_GB |
| dcterms.dateAccepted | 2020-11-13 | |
| rioxxterms.version | VoR | en_GB |
| rioxxterms.licenseref.startdate | 2021-01-22 | |
| rioxxterms.type | Journal Article/Review | en_GB |
| refterms.dateFCD | 2021-03-04T11:54:41Z | |
| refterms.versionFCD | VoR | |
| refterms.dateFOA | 2021-03-04T11:56:21Z | |
| refterms.panel | A | en_GB |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © The Author(s) 2021. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.